基于机器学习的即时单时间点剂量学有效半衰期特征研究
本研究纳入22例接受[68Ga]Ga-PSMA-11预治疗成像及后续[177Lu]Lu-PSMA I&T放射性配体治疗的患者,利用机器学习基于预治疗PET和临床数据预测左肾、右肾、肝、脾的有效半衰期,实现即时单时间点剂量学。结果显示第一场景聚合2和20小时时间点时所有器官时间积分活度平均差异低于27%,仅用初始PET/CT数据预测后续周期有效半衰期与每周期前PET数据结果无统计学显著差异(P>0.05)。
要点
- 即时单时间点剂量学利用预治疗数据预测有效半衰期,左肾、右肾、肝、脾分别采用治疗后2、20、43、69小时时间点。
- 第一场景聚合2和20小时数据,所有器官时间积分活度平均差异低于27%。
- 仅用初始PET/CT数据预测后续周期有效半衰期,与每周期前PET数据结果无统计学显著差异(P>0.05)。
核心结论
- 初步结果证明可利用预治疗数据预测有效半衰期,并在放射性配体治疗后短时间灵活实现单时间点剂量学。
- 所提方法可能加速剂量学在门诊或短程住院治疗等更广泛场景中的应用。
研究设计与样本
- 研究纳入22例接受[68Ga]Ga-PSMA-11预治疗成像及后续[177Lu]Lu-PSMA I&T放射性配体治疗的患者数据进行分析。
- 开发机器学习模型预测左肾、右肾、肝、脾的有效半衰期,并用于估算时间积分活度和吸收剂量。
- 即时单时间点剂量学结果与多时间点法及先前提出的Hänscheid法进行比较,包含两个预测场景:使用每个治疗周期前数据和使用第一周期数据。
主要发现
- 即时单时间点法引入治疗后早期时间点:左肾2小时、右肾20小时、肝43小时、脾69小时。
- 第一场景聚合2和20小时数据,所有器官时间积分活度平均差异低于27%。
- 与Hänscheid法最佳结果(肾69小时;肝和脾20小时)比较,2小时时除脾(P=0.1370)外几乎所有器官差异有统计学意义(P<0.001)。
- 20小时时右肾、肝、脾无显著差异,左肾差异有统计学意义(P<0.01)。
- 仅用初始PET/CT数据预测后续周期有效半衰期,与每周期前PET数据结果比较所有周期均无统计学显著差异(P>0.05)。
局限性
- 原文称本研究为初步结果,证明的是概念。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Single-time-point (STP) image-based dosimetry offers a more convenient approach for clinical practice in radiopharmaceutical therapy (RPT) compared with conventional multiple-time-point image-based dosimetry. Despite numerous advancements, current STP methods are limited by the need for strict and late timing in data acquisition, posing challenges in routine clinical settings. This study introduces a new concept of instant STP (iSTP) dosimetry, achieved by predicting the effective half-life (T eff) of organs using machine learning applied on pretherapy patient data (PET and clinical values). Methods: Data from 22 patients who underwent pretherapy 68Ga-gallium N,N-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N-diacetic acid ([68Ga]Ga-PSMA-11) imaging and subsequently [177Lu]Lu-PSMA I&T RPT were analyzed. A machine learning model was developed for T eff predictions for the left and right kidneys, liver, and spleen subsequently used to estimate time-integrated activity and absorbed dose. iSTP results were compared against multiple-time-point and previously proposed Hänscheid methods. Our method comprised 2 different prediction scenarios, using data before each therapy cycle and from the first cycle. Results: The iSTP method introduced early posttherapy time points (2, 20, 43, and 69 h) for the left kidney, right kidney, liver, and spleen. Dosimetry in the first scenario, aggregating 2 and 20 h, achieved mean differences in time-integrated activity below 27% for all organs. To assess the feasibility, these time points were compared with the best results from the Hänscheid method (kidneys, 69 h; liver and spleen, 20 h). At 2 h, a significant difference (P < 0.001) was found for almost all organs except for the spleen (P = 0.1370). However, at 20 h, no significant differences were found for the right kidney, liver, and spleen, apart from the left kidney (P < 0.01). In the scenario using only the initial PET/CT data to predict T eff for subsequent cycles, iSTP dosimetry achieved no statistical significance (P > 0.05) for all cycles in comparison to results using PET data before each therapy cycle. Conclusion: Our preliminary results prove the concept for prediction of T eff with pretherapy data and achieving STP shortly and flexibly after the RPT. The proposed method may expedite the application of dosimetry in broader contexts, such as outpatient or short-duration inpatient treatment.
引用
- Gomes CV, Chen Y, Rauscher I, et al. Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning. J Nucl Med. 2025. PMID: 40113223. doi:10.2967/jnumed.124.268175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。